For which of the following populations is nicotine replacement therapy NOT recommended?

Nicotine replacement therapy (NRT) is often used to help individuals quit smoking by providing a controlled dose of nicotine without the harmful effects of tobacco. While it can be beneficial for many individuals, certain populations need careful consideration due to potential risks.

In the case of pregnant women, NRT is generally not recommended as the use of nicotine during pregnancy can be associated with adverse outcomes. These may include low birth weight, preterm birth, and developmental issues in the fetus. Therefore, while the risks of smoking are well-documented, the use of nicotine in any form during pregnancy is approached with caution. Health care providers often recommend non-pharmacological smoking cessation strategies for pregnant women instead, such as counseling and support programs.

In contrast, NRT can be appropriate for adults, older adults, and adolescents when used under supervision. These groups can typically benefit from the use of NRT as it helps to alleviate withdrawal symptoms and cravings associated with quitting smoking. Individual assessments are still necessary to evaluate the overall health and risks for each person within these categories.

The guidelines emphasize the importance of making informed choices, especially for vulnerable populations like pregnant women, where the potential risks necessitate alternative approaches to support cessation.